Authors: DURLIK M GACIONG Z SOLUCH L ROWINSKA D RANCEWICZ Z KOZLOWSKABOSZKO B LEWANDOWSKI Z ROWINSKI W SZMIDT J LAO M

Citation: M. Durlik et al., EFFECT OF CHRONIC LIVER-DISEASE ON CLINICAL OUTCOME IN RENAL-ALLOGRAFT RECIPIENTS, Transplantation proceedings, 29(1-2), 1997, pp. 787-790

Authors: DURLIK M GACIONG Z SOLUCH L ROWINSKA D KOZLOWSKABOSZKO B ROWINSKI W SZMIDT J LAO M

Citation: M. Durlik et al., RESULTS OF KIDNEY-TRANSPLANTATION IN HBSAG AND ANTI-HCV SEROPOSITIVE RENAL-ALLOGRAFT RECIPIENTS, Transplantation proceedings, 28(6), 1996, pp. 3459-3460

Authors: LAO M ROWINSKI WA SZMIDT J WALASZEWSKI J FRUNZE S PAZIK J NOWACKA E ROWINSKA D GRADOWSKA L

Citation: M. Lao et al., LIVING DONOR RENAL TRANSPLANTATIONS IN POLAND, Transplantation proceedings, 28(6), 1996, pp. 3573-3574

Authors: DURLIK M GACIONG Z SOLUCH L WALECKAZIELECKA B RANCEWICZ Z ROWINSKA D ROWINSKI W SZMIDT J LAO M

Citation: M. Durlik et al., RISK OF CHRONIC LIVER-DISEASE IN HBSAG AND OR ANTI-HCV-POSITIVE RENAL-ALLOGRAFT RECIPIENTS/, Transplantation proceedings, 28(1), 1996, pp. 50-51

Authors: DURLIK M GACIONG Z RANCEWICZ Z ROWINSKA D WYZGAL J KOZLOWSKA B GRADOWSKA L LAO M NOWACZYK M KORCZAKKOWALSKA G GORSKI A

Citation: M. Durlik et al., RENAL-ALLOGRAFT FUNCTION IN PATIENTS WITH CHRONIC VIRAL HEPATITIS-B AND HEPATITIS-C TREATED WITH INTERFERON-ALPHA, Transplantation proceedings, 27(1), 1995, pp. 958-959